Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079856 · ClinicalTrials.gov registry record · NA
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
A NA study of Drug Use and Sex Behavior, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT03079856: Completed NA study of Drug Use and Sex Behavior, sponsored by University of Michigan.
NCT03079856 is a NA study of Drug Use and Sex Behavior that has completed, run by University of Michigan. The registered enrollment target is 63 participants, below the 221-participant average among 25 other Drug Use trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079856, a NA study of Drug Use and Sex Behavior, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.
Primary Outcome
60-day Timeline Follow-Back (TLFB) will be used to assess total days of any substance use.
Conditions Studied
Interventions
- BEHAVIORAL Brief Intervention
Study Locations (1)
Michigan
- Hurley Medical Center - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2018-08-13 |
| Phase | NA |
What the finished NCT03079856 record still lists
NCT03079856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 221-participant average among 25 other Drug Use trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Drug Use appearing as the primary indexed condition, and to 1 intervention - of which Brief Intervention is the first listed.
NCT03079856 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03079856 about?
NCT03079856 is a clinical study titled "Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER". This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.
What is the current status of trial NCT03079856?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2017-10-09. Estimated completion is 2018-08-13.
What conditions does trial NCT03079856 study?
This clinical trial studies the following conditions: Drug Use, Sex Behavior.
What interventions are being tested in trial NCT03079856?
The interventions under investigation include: Brief Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03079856?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03079856 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03079856's enrollment target sits among peer trials
63 17th of 25 higher than 9 of 25 other Drug Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Families With Pride ("Familias Con Orgullo").
RECRUITING · NA
-
Lakota Family Acceptance Project
RECRUITING · NA
-
Mental Health in Primary Care
RECRUITING · NA
-
Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Harm Reduction Services
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI